analyzed data from The Cancer Genome Atlas (TCGA) and reported that among 338 cases (7 with fibrolamellar carcinomas and 331 with conventional HCC), 128 cases had mutations in the CTNNB1, APC, and Axin genes (38%). The gene discussed is APC; the disease is hepatocellular carcinoma.